Global Law Office represents inbound and outbound acquirers, target companies, and selling shareholders, offering expertise in matters such as acquisitions by auctions, corporate restructuring, leveraged buyouts, and share repurchases of public companies. The firm is particularly adept at managing cross-border M&A transactions involving state-owned enterprises and listed companies, addressing issues including industrial compliance, foreign investment, and national security review. The department is jointly led by Jinrong Liu, who covers various industries including TMT, new energy, and logistics; Alex (Chengwei) Liu, with expertise in state-owned assets related transactions and the takeover and restructuring of public companies; and Shifang Guo, noted for her ‘extensive experience and professional insights into cross-border mergers and acquisitions’.  Huawei Lin departed to establish Kingland Partners in August 2024.
Legal 500 Editorial commentary
Phone
86-10-6584-6599
Email
Profile

Profile

Position

Alex Liu focuses on mergers and acquisitions, private equity investment & financing, and capital markets, with established expertise on takeover and restructuring of public companies, state-owned assets related transactions, cross-border M&A and red-chip restructuring.

In the field of merger and acquisitions, Alex has been involved in many representative deals, which include:

Takeover of control, such as,

  • Infore Group’s over RMB 8.88 billion takeover of KUCA (603816.SH);
  • Broadex’s (300548.SZ) takeover by YOFC (601869.SH; 06869.HK);
  • Orient Zirconic’s (002167.SZ) takeover by LB Group (002601.SZ);
  • Meiya Pico’s (300188.SZ) takeover by SDIC;
  • Sichuan Shuangma’s (000935.SZ) takeover by IDG Capital; and
  • Cangzhou Dahua’s (600230.SH) sale by a central SOE.

Restructuring by public companies, such as,

  • Zoomlion’s (000157.SZ; 01157.HK) carve-out by way of RoadRover’s (002813.SZ) backdoor listing;
  • Synermore Biologics’ sale to NUCIEN (688189.SH);
  • NuClover’s sale to Jieqiang Equipment (300875.SZ);
  • affiliates’ restructuring by SOE YNHC (001896.SZ); and
  • merger of Huabei Expressway (000916) by China Merchants Highway.

Cross-border M&A transactions, such as,

  • over RMB 3.3 billion strategic investment into CGN’s Brazilian subsidiary;
  • over RMB 18.47 billion takeover of Israel’s ADAMA by Sanonda (000553.SZ);
  • merger integration of Xiamen Port involving three A-shares and two HK listed companies;
  • combination of CR Pharmaceutical and Beijing Pharmaceutical involving four A-shares companies;
  • acquisition of Tianjin Port (600717.SH) by Tianjin Port Development (00382.HK) through shares exchange;
  • RTO of HanKore Environment (U9E.SGX) by Everbright International (00257.HK);
  • VSA injecting properties by CR Land (01109.HK);
  • sale of TNUVA to Bright Food by APAX Fund; and
  • acquisition of skiing resorts in Yabuli by Melco.

Red-chip or VIE restructuring, Alex’s representative clients include Xiyun, Douyu, EASOU Technology, Bangcle, Chunyu Yisheng, Baixing.com, and Baofeng Group etc.

In the field of PE investment and financing, Alex has represented numerous RMB or USD funds such as China Merchants Capital, CDB Capital, CIIF, Hony Capital, Goldstone, and Jinrong Street Capital etc., in investments ranging from technology, healthcare to energy sectors.

In capital markets, Alex has advised on the listings or additional issues on the stock exchanges in Shanghai, Shenzhen, Beijing, Hong Kong or US, including the IPO of China Resources Microelectronics (688396.SH) on SSE STAR, the first case in Chinese capital markets of an offshore red-chip company; Douyu.com (DOYU) and VisionChina (VISN)’s Nasdaq listing; Tong Ji Tang’s NYSE listing; Dynasty (00828), Huaying Highway (01823), Hongba Digital (00802) and Sanlin Global (019020)’s HKSE listing; Vanke’s B to H share conversion; and the delisting of Zhengzhou Gas, etc.

Career

2011 – present Global Law Office

2010 – 2011 Jones Day (Beijing)

2004 – 2009 Global Law Office

Languages

Chinese,English

Education

2009 – 2010 UC Berkeley, LL.M.

2001 – 2004 Renmin University of China, LL.M.

1997 – 2001 Northeastern University, LL.B.

Content supplied by Global Law Office

Testimonials

Collated independently by Legal 500 research team.

  • ‘Global Law Office is very familiar with mergers and acquisitions within the life sciences and healthcare sectors. Their advice is highly practical and often includes innovative solutions for project implementation.'

  • 'Shifang Guo's team in Shenzhen not only demonstrates robust legal expertise but also possesses a deep and thorough understanding of our industry and business needs. They respond promptly to our legal requirements, providing excellent service and maintaining a high standard. Guo’s team has particular experience in the TMT sector, showing proficiency in industry regulations, legal due diligence, key business terms, and negotiation strategies.'

  • 'Shifang Guo is highly proficient in Chinese law and brings extensive experience and professional insights into cross-border mergers and acquisitions, a rare asset in the South China legal market. She is diligent and responsible, responding swiftly and collaborating effectively with colleagues across legal, investment, and finance departments.'

Key clients

  • Primavera Capital
  • Luxshare Precision Industry Company Limited
  • Blackstone
  • Warburg Pincus
  • Shenzhen SF Taisen Holdings (Group) Inc.
  • Full-Life Technologies
  • China Merchants Expressway Network & Technology Holdings Co., Ltd.
  • TC Pharmaceutical
  • Jiangxi Copper
  • Huaxia Financial Leasing Co., Ltd.
  • GLP (Zhuhai) Equity Investment Management Co., Ltd.
  • China Life Asset Management Co., Ltd.
  • CGNPC Energy International
  • Shandong High-Speed Holdings
  • Infore Group
  • BCS Automotive Interface Solutions

Work highlights

Provided legal counsel to CDH in the acquisition of ZJGX shares and subsequent board reorganization.
Assisted Infore Group in purchasing a controlling interest in Kuka Home.
Assisted CMET in acquiring Road King's highway assets.